Clinical Trials Logo

Pregnancy Complications clinical trials

View clinical trials related to Pregnancy Complications.

Filter by:

NCT ID: NCT05265741 Recruiting - Clinical trials for Pregnancy Complications

Gestational Diabetes Mellitus (GDM) in Pregnant Women

Start date: November 9, 2021
Phase:
Study type: Observational

The purpose of the trial is to discover and predict the development of GDM of pregnant women in their first trimester.

NCT ID: NCT05264779 Recruiting - Premature Birth Clinical Trials

The Periviable GOALS Decision Support Tool

Start date: June 6, 2022
Phase: N/A
Study type: Interventional

The Periviable GOALS (Getting Optimal Alignment around Life Support) decision support tool (DST) is meant to facilitate informed shared decision-making regarding neonatal resuscitation for families facing the threat of a periviable delivery (deliveries occurring between 22 0/7 - 25 6/7 weeks gestational age). It is designed for parents to review independent of their clinician, and is intended to supplement, not replace, clinician counseling. The focus of the DST is the provision of patient-centered outcomes information and assistance with values clarification regarding neonatal outcomes. This is a multisite, randomized controlled trial to test the effect of the Periviable GOALS DST on shared decision making and decision satisfaction. The investigators hypothesize that participants who utilize the GOALS DST will have improved shared decision making and higher decision satisfaction.

NCT ID: NCT05234125 Recruiting - Pregnancy Related Clinical Trials

Better Lifestyle Counseling for African American Women During Pregnancy

BETTER
Start date: August 16, 2022
Phase: N/A
Study type: Interventional

The purpose of this randomized controlled trial is to establish the effectiveness of a culturally targeted and individually tailored behavioral intervention to promote maternal glucose metabolism in African American women.

NCT ID: NCT05197387 Recruiting - Clinical trials for Cholestasis of Pregnancy

Association of Intrahepatic Cholestasis of Pregnancy and Chronic Placental Inflammation

INTREPIDE
Start date: June 21, 2022
Phase:
Study type: Observational

This observational prospective study will help to determine if an immune process similar to allograft rejection is responsible for the occurrence of an intrahepatic cholestasis of pregnancy (ICP). If so, it would suggest the potential benefit of immunomodulatory therapeutics.

NCT ID: NCT05182541 Recruiting - Psychology Clinical Trials

Psychological Screening and Nursing of Twin Pregnancy

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Objectives This research will screen the psychological problems of twin pregnant women step by step and detect early and treat early in order to reduce the incidence of mental diseases and promote the health of mother and baby.

NCT ID: NCT05132829 Recruiting - Preterm Birth Clinical Trials

Azithromycin to Improve Latency in Exam Indicated Cerclage Control Trial

ALEC
Start date: December 20, 2021
Phase: Phase 4
Study type: Interventional

Azithromycin is an antibiotic that is effective against bacteria that been associated with preterm birth (PTB). The purpose of this study is to evaluate if the addition of azithromycin prior to exam indicated cerclage prolongs gestation. A cerclage is a suture placed in the cervix to prolong gestation.

NCT ID: NCT05127252 Recruiting - Contraception Clinical Trials

Impact of the Microbiome on Time to Pregnancy and Pregnancy Outcomes in Fertile Women Attempting to Conceive

SweBioFertil
Start date: April 10, 2023
Phase:
Study type: Observational [Patient Registry]

This study aims to investigate the microbiome of women with previously proven fertility who plan to become pregnant.

NCT ID: NCT05114096 Recruiting - Preterm Birth Clinical Trials

Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS)

SNACS
Start date: July 20, 2023
Phase: Phase 4
Study type: Interventional

Antenatal corticosteroids (ACS) reduce the risks of neonatal death and morbidities in preterm infants, such as respiratory distress syndrome. The standard of care for pregnant people at risk of preterm birth includes 2 doses of Celestone (for a total of 24 mg in Canada, or 22.8 mg in Australia) to accelerate fetal lung maturity. The investigators plan to conduct a randomized controlled trial to determine whether half the usual dose (12 mg in Canada, or 11.4 mg in Australia) of Celestone is non-inferior to the standard double doses.

NCT ID: NCT05089175 Recruiting - Clinical trials for Pregnancy Complications

The Investigation of the Prediction Model and Prevention Strategy of Serious Pregnancy Complications in Hypertensive Disorders of Pregnancy Based on the Chinese Population

HDP-RPP
Start date: November 30, 2021
Phase:
Study type: Observational [Patient Registry]

1. Evaluation of the efficacy of aspirin in preventing preeclampsia and its serious complications during pregnancy and postpartum. 2. To establish a risk prediction model for severe pregnancy complications in pregnant women with hypertensive disorders of pregnancy.

NCT ID: NCT05084339 Recruiting - Clinical trials for Bariatric Surgery Status Complicating Pregnancy

Glucose Homeostasis, Metabolomics and Pregnancy Outcomes After Bariatric Surgery

GLORIA
Start date: January 25, 2023
Phase:
Study type: Observational

The aim of the GLORIA study is to determine whether an altered glucose metabolism (with more hypoglycaemia and glycaemic variability) and altered metabolomics during pregnancy after bariatric surgery contribute to the increased risk for adverse pregnancy outcomes such as small-for-gestational age infants. In addition, the investigators also aim to evaluate whether continuous glucose monitoring (CGM) can be used to diagnose gestational diabetes (GDM).